However, this study did not validate the molecular function of these biomarkers and the existence and functional role of the ceRNA network, TF-mRNA network, and key gene-drug network in NAFLD, which is a major limitation. The gene discussed is TF; the disease is metabolic dysfunction-associated steatotic liver disease.